Simplify Logo

Full-Time

Profound Therapeutics: Senior Scientist

Computational Biology/Single Cell & Spatial Omics

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Biotechnology firm creating health and sustainability solutions

Biotechnology
Healthcare

Mid, Senior

Boston, MA, USA

Category
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Python
R
Requirements
  • PhD trained in bioinformatics, computational biology or other relevant field with 2+ years of experience post-PhD
  • Working knowledge of NGS-based genetics, genomics (especially 10X-based single-cell and spatial omics) and other non-NGS-based omics data processing and statistical analyses
  • Experience in applying single-cell and/or spatial omics approaches in patients’ tissues, primary cells or cell lines to identify causal genes involved in disease pathophysiological pathways and to address problems in the life sciences and generate actionable biological insight in diseases relevant to cardio-metabolic, inflammatory, neurodegenerative and/or neuropsychiatry disorders
  • Ability to conduct statistical modeling and computational analyses on single-cell and/or spatial omics, especially cell type/state clustering, trajectory analysis, cell-cell communication/interaction, spatial cell-cell interactions
  • Demonstrated industry experience or academic achievement, as evidenced by publications or contribution to widely used codebase
  • Skilled user of command-line programming languages Python and/or R; 10X single-cell and spatial omics tools, deep learning modeling; publicly available single-cell/spatial omics browsers; as well as commonly used cloud-based platforms (such as Human cell atlas, CZ CELLxGENE Discover, Bioturing, Terra, Seven Bridge, etc… to access such data)
  • A commitment to reproducible computational research
  • Excellent communication and presentation skills
Responsibilities
  • Identify and process publicly available and internal generated single-cell and spatial transcriptome/multi-omics datasets using statistical and bioinformatics techniques to create meaningful biological insight
  • Ensure multi-omics data analysis are documented and reproducible
  • Develop and implement single-cell and spatial data integration methods and tools to integrate data from proteomics and high-content imaging to identify, prioritize, and characterize novel therapeutic targets
  • Collaborate in cross-disciplinary teams including wet-lab and data scientists to build bioinformatic modeling, computational pipelines, data summaries, visualization dashboards for high throughput leading-edge multi-omics technologies
  • Perform integrative and functional analyses to contribute to the understanding of phenotypes of drug perturbation, mechanism of action, and the identification of key response signatures
  • Lead develop ProFound’s multi-omics platform for maximal impact on biological characterization and the drug development pipeline

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.

Help us improve and share your feedback! Did you find this helpful?